Technology Overview | Intellectual Property
IP Overview
BioSET® has a robust and developing portfolio of intellectual property. Among a total of 24 U.S. patents, BioSET has been issued 4 patents that pertain specifically to our peptide biomimetic technology, with additional patents pending.
Below is a select list of the company’s U.S. Patents:
Patents related to BioSET peptide designs:
- 7,528,105 Heterodimeric chain synthetic heparin-binding growth factor analogs
- 7,482,427 Positive modulator of bone morphogenic protein-2
- 7,414,028 Growth factor analogs
- 7,166,574 Synthetic heparin-binding growth factor analogs
Patents related to peptide coating technologies:
- 7,468,210 Cross Linked Heparin Coatings and Methods
- 7,297,343 Bioactive medical films
- 6,921,811 Bioactive coating composition and methods
- 6,342,591 Amphipathic coating for modulating cellular adhesion composition and methods
BioSET also has a number of published applications dealing with additional peptide designs and specific applications of the peptide technology.